INCY
$111.57 · +2.7% today · −1.6% 5d · −4.4% 3m · +31.7% 1y
Daily score2
Weekly score0
Long-term score70
Close
Scores (0–100)
Components — latest (2026-10-14)
Close
111.57
1D return
+2.7%
5D return
−1.6%
Rel volume
1.05
CMF 20
-0.28
OBV slope 20
-0.51
Up-vol ratio 10
0.22
Short ratio
0.71
Short ratio Δ
+0.5%
Persistence 10
0.00
Inflow mean 5d
-1.25
Inflow mean 60d
-0.00
Momentum 12-1
+43.7%
% of 52w high
+85.9%
vs 200d
+3.9%
Volatility 60d
+32.4%
Dollar vol 20d
$214.53M
Insider buys 90d
$0
Insider buyers 90d
0.00
Revenue growth
+37.7%
Fundamentals — Incyte · Health Care
as of 2026-10-22- P/E
- 18.4
- P/B
- 3.74
- ROE
- 20.3%
- Operating margin
- 29.5%
- Debt / equity
- 0.00
- FCF yield
- 6.0%
- Years profitable
- 5/5
- BM score
- 97
- Moat flag
- Yes
Insider trades (Form 4)
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-19 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 2.6K | $112.71 | $297.8K |
| 2026-09-17 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 9.2K | $120.50 | $1.11M |
| 2026-09-17 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 14.0K | $120.49 | $1.69M |
| 2026-08-20 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 10.8K | $125.56 | $1.36M |
| 2026-08-14 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 10.8K | $120.04 | $1.30M |
| 2026-08-07 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2.2K | $123.99 | $273.6K |
| 2026-08-07 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 10.6K | $122.69 | $1.31M |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 85 | $122.19 | $10.4K |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 326 | $121.69 | $39.7K |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2.3K | $119.41 | $273.8K |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2.9K | $119.40 | $342.0K |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 1.6K | $119.51 | $196.4K |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 1.6K | $119.38 | $196.0K |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 6.1K | $120.43 | $729.2K |
| 2026-08-04 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 15.9K | $119.70 | $1.90M |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 4.7K | $119.39 | $560.5K |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 14.7K | $119.46 | $1.75M |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 5.3K | $119.42 | $636.7K |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2.2K | $119.47 | $261.3K |
| 2026-08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 6.2K | $119.43 | $737.0K |
| 2026-07-20 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Sell | 1.1K | $115.01 | $125.7K |
| 2026-07-20 | Stein Steven H | CMO & Head of Late-Stage Dev. | Sell | 1.9K | $114.73 | $215.3K |
| 2026-07-16 | Stein Steven H | CMO & Head of Late-Stage Dev. | Sell | 28.2K | $113.05 | $3.19M |
| 2026-06-08 | Tray Thomas | Principal Accounting Officer | Sell | 2.6K | $100.00 | $263.9K |
| 2026-05-28 | Tray Thomas | Principal Accounting Officer | Sell | 2.1K | $97.35 | $199.7K |
| 2026-05-21 | Clancy Paul J | Director | Sell | 15.0K | $94.93 | $1.42M |
| 2026-04-21 | CAGNONI PABLO J | President, Global Head of R&D | Sell | 18.7K | $96.50 | $1.80M |
Congress trades
No congressional trades on file for INCY.